Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic acid and B-vitamin therapy for hyperhomocysteinemia and left ventricular hypertrophy in maintenance hemodialysis patients
ChiCTR1800015116Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of folic acid, pyridoxine and cyanocobalamin in hyperhomocysteinemia and left ventricular hypertrophy (LVH) (2 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoints: homocysteine and left ventricular hypertrophy. Started Mar 2018; status: recruiting.
02
Drugs
folic acidpyridoxinecyanocobalamin
03
Conditions
hyperhomocysteinemialeft ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on ChiCTR1800015116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015116.